The era is paradoxical. With the coronavirus crisis, there has probably never been more talk of science in the media than in political discourse. The rate of reproduction, the cytokine storm, the protective antibodies are in everyone’s mouth. And yet the streak is not a triumph of reason. We feel like a bitter aftertaste in … Read more
The medico-political-media soap opera of hydroxychloroquine, an abundance of criticized scientific studies, intimate convictions and even irrationality between “pro” or “anti”, begins a new sequence of his crazy story. Title of this episode: the halt. The story started on Friday. In a resoundingly echoing study published that day in the prestigious and very serious medical … Read more
Question asked by Tsarorius on 05/04/2020 Hello, You are asking us about a controversy that arose in April from the presentation of work by researchers at the IHU Méditerranée infection on the effects of hydroxychloroquine (HCQ) and azithromycin in people with Covid-19. With this question: did the study follow the procedures relating to patient protection? … Read more
This is a sharp, very technical article, pre-published (and therefore not yet proofread and validated by peers) on April 30 on the platform. BioRxyv. It reveals that there are two strains of Sars-Cov-2 (the virus responsible for Covid-19) circulating since the start of the pandemic. “This mutation is not new, but what is it is … Read more
In Madagascar, the fight against coronavirus has taken the form of a caramel brown liquid. Distributed in plastic bottles, five-liter cans or in the form of tea bags for infusion, the product, called Covid-Organics (CVO), would be effective in “seven days” according to Andry Rajoelina. The Madagascan president no longer appears in public without his … Read more
A big slap. This is what has just received the researchers from the AP-HP in charge of conducting a clinical trial on Tocilizumab, a monoclonal antibody commonly used in the treatment of rheumatoid arthritis. On April 27, in a press release, the AP-HP welcomed the fact that in view of the first conclusions of the … Read more
Professor Bernard Begaud, pharmacologist, former president of the University of Bordeaux, chaired the monitoring committee for clinical trials within the French Medicines Agency (ANSM) for more than fifteen years. He returns for Release on chloroquine, and points to the inconsistency and lack of coordination of the trials in progress. After three months of waiting, do … Read more
First glimmer of hope on the Cov2 treatment front. While 2,000 patients infected with Cov2 are in France engaged in clinical trials to test the possible benefit of existing drugs or molecules, the Assistance Publique-Hôpitaux de Paris (AP-HP) has just made public, for “ethical reasons “, the preliminary but promising results of a study on … Read more
In the space of a few hours, dozens of pharmacists in the Grand-Est region received the same phone call. At the end of the line, a man introduces himself as the assistant to Professor Jérôme Salomon, director general of public health and figure in the fight against the Covid-19 epidemic. His voice imbued with gravity, … Read more
We only talk about her, we believe strongly. And in this second week of general confinement, while France now has 860 dead (186 more in twenty-four hours) and more than 2,000 patients in intensive care, chloroquine is on the verge of being presented as the miracle cure against the coronavirus, and the grumpy would delay … Read more